# Correction: PEGylated liposomal metformin overcomes pharmacokinetic barriers to trigger potent mitochondrial disruption and cell cycle arrest in hepatocellular carcinoma

**Authors:** Zeinab A. Elzanaty, Medhat W. Shafaa, Seifeldin Elabed, Mohamed M. Omran

PMC · DOI: 10.1038/s41598-025-25898-1 · Scientific Reports · 2025-10-28

## Full-text entities

- **Diseases:** hepatocellular carcinoma (MESH:D006528)
- **Chemicals:** metformin (MESH:D008687)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12568979/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12568979/full.md

---
Source: https://tomesphere.com/paper/PMC12568979